NAD+ Supplements After 50: What NMN and NR Actually Do — and What They Do Not

• Adults over 50 who are curious about the ageing-biology research and want to follow it without expecting a proven benefit.
• People whose clinician has recommended a B3 form for a specific, established reason such as a diagnosed deficiency or lipid management.
• Anyone who has already covered the higher-evidence basics — resistance exercise, adequate protein, sleep, blood-pressure and glucose control — and understands this is an optional experiment on top of them.

Who should be cautious

• People with a current or past cancer diagnosis. NAD+ is used by dividing cells, and the effect of raising NAD+ in people with cancer is not established. Discuss this with your oncology team before taking any precursor.
• People with liver disease, or anyone taking high-dose niacin forms, which carry liver-related risks at high intakes.
• People with gout or elevated uric acid, and people with diabetes, because nicotinic acid can affect uric acid and glucose control.
• Anyone taking prescription medicine — bring the actual bottle to your pharmacist so the specific form and amount can be checked.
• People who are pregnant or breastfeeding; supplemental NMN and NR have not been established as safe in pregnancy.
• Anyone scheduled for surgery. Tell your surgeon and anaesthetist about every supplement you take, and ask whether to stop it before a planned procedure — many teams ask patients to pause supplements one to two weeks beforehand.

• NR: human trials have most commonly used roughly 250 to 1,000 mg per day, with some studies running up to about 2,000 mg per day for shorter periods.
• NMN: published human trials have most commonly used roughly 250 to 1,250 mg per day over periods of several weeks to a few months.
• Nicotinamide and nicotinic acid have long-established intake references and medical dosing that differ entirely from the amounts above; high-dose niacin is a prescribed-strength intervention, not a casual addition.
• Trial durations are short relative to a human lifespan. Most run 6 to 12 weeks; the longest published NR trials run to about a year.

These figures describe what researchers have studied, not a dose recommendation. Because the benefit in humans is unproven and long-term data is limited, the amount that is appropriate for any individual — if any — is a decision for that person and their clinician.

• In randomised trials, NR and NMN have generally been well tolerated. Reported side effects are usually mild: nausea, digestive upset, headache or flushing.
• Long-term safety beyond about a year has not been established for either compound, and no trial has followed older adults for the multi-year periods over which people actually intend to take them.
• People with a current or past cancer diagnosis should not start a NAD+ precursor without oncology input; the effect of increasing NAD+ availability on tumour biology is unresolved.
• High-dose nicotinic acid can cause flushing, raise uric acid, affect glucose control and, at sustained high intakes, affect the liver. It belongs under medical supervision.
• Regulatory status differs by country and has shifted for NMN in the United States, which affects availability and how products are labelled and marketed.
• Not established as safe in pregnancy or breastfeeding.
• Tell your surgeon and anaesthetist about every supplement you take, and ask whether to stop it before a planned procedure — many teams ask patients to pause supplements one to two weeks beforehand.
• Bring the actual bottle, or a photograph of the label, to your appointments so your pharmacist can check the specific form and amount against your medicine list.

1. 1Decide first whether you want a precursor at all, given that the human benefit is unproven. If the honest answer is 'I am experimenting', budget accordingly.
2. 2Prefer the form with the most human data if you proceed. NR currently has the larger randomised human evidence base; NMN has more marketing.
3. 3Read the supplement facts panel for the milligram amount of the precursor itself, not the weight of a proprietary blend. If you cannot compare it to a published trial amount, the product is unevaluable.
4. 4Discount ingredient-count marketing. A long list of resveratrol, quercetin and assorted extracts is not evidence of a stronger product; it usually means less of the precursor.
5. 5Look for third-party testing (for example USP or NSF verification, or a published certificate of analysis with a batch number) — purity and identity problems have been documented in this category.
6. 6Ignore any product or clinic promising to reverse biological age, reset epigenetic clocks or extend lifespan. No supplement has demonstrated this in humans.
7. 7Check for a lot number and expiry date, and buy from a seller who can trace both.

We do not publish prices and we do not link to a checkout. Where a product link is not configured, nothing is linked out at all.

• [1]NIH Office of Dietary Supplements — Niacin fact sheet for health professionals (NAD+ precursor forms, intake references and upper limits).
• [2]PubMed — randomised controlled trials of nicotinamide riboside in humans (NAD+ elevation and clinical outcomes).
• [3]PubMed — randomised clinical trials of nicotinamide mononucleotide (NMN) in humans.
• [4]National Institute on Aging — dietary supplements and older adults, including guidance on unproven anti-ageing claims.
• [5]U.S. Food and Drug Administration — questions and answers on dietary supplements, including regulation and label claims.
• [6]Citation placeholderDirect evidence on sirtuin activity measured in humans following NMN supplementation — no adequate human source has been identified; this is a gap in the literature rather than a pending citation.

Placeholders are deliberate. We would rather show you that a reference is still being verified than publish a source we have not checked. See How We Review Supplements.

This article is educational and is not medical advice. It does not diagnose, treat or prevent any condition. Supplements can interact with prescription medicine and are not appropriate for everyone. Talk to your physician or pharmacist before starting, stopping or changing anything you take — particularly if you are pregnant or breastfeeding, have kidney, liver or heart disease, take prescription drugs, or have surgery scheduled. Read our full medical disclaimer.